February 10, 2016
As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.
February 1, 2016
Researchers at UC Davis and Lawrence Livermore and Los Alamos national laboratories have created a chemotherapy-resistant line of bladder cancer cells to study how tumors become resistant to chemotherapy and identified molecular changes that could drive that resistance.
January 29, 2016
African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.
January 19, 2016
An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells.
January 15, 2016
UC Davis investigators have found that telecommunication systems that provide remote monitoring and access to specialty care in intensive care units (ICUs) are cost-effective in most cases and can even be cost-saving in certain circumstances, making this intervention potentially economically favorable compared with other health-care services.
January 11, 2016
A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next.
January 11, 2016
In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women.
December 17, 2015
Researchers at UC Davis and other institutions have shown that isavuconazole, a new treatment for invasive mold diseases such as Aspergillus, has fewer side effects than voriconazole and is just as effective. These results are good news for leukemia and lymphoma patients, who can be vulnerable to these opportunistic infections. The study was published Dec. 9 in The Lancet.
December 9, 2015
Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.
December 3, 2015
In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.